Nagarakanti, R., & Brückmann, M. (2015). Comparison of characteristics and outcomes of dabigatran versus warfarin in hypertensive patients with atrial fibrillation (from the RE-LY trial). The American journal of cardiology, 116(8), . https://doi.org/10.1016/j.amjcard.2015.07.032
Chicago Style (17th ed.) CitationNagarakanti, Rangadham, and Martina Brückmann. "Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients with Atrial Fibrillation (from the RE-LY Trial)." The American Journal of Cardiology 116, no. 8 (2015). https://doi.org/10.1016/j.amjcard.2015.07.032.
MLA (9th ed.) CitationNagarakanti, Rangadham, and Martina Brückmann. "Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients with Atrial Fibrillation (from the RE-LY Trial)." The American Journal of Cardiology, vol. 116, no. 8, 2015, https://doi.org/10.1016/j.amjcard.2015.07.032.